account_id none on file
legal_name Zura Bio Ltd
ticker ZURA
cik 1855644
domain zurabio.com
linkedin_company_url https://www.linkedin.com/company/zura-bio-limited/about/
entry_point_account_id none on file
name Zura Bio Limited
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 3 executives 4 family 0
why_nownone on file
callsnone on file
filings
The decrease was primarily due to lower consulting and recruiting fees in the second quarter of 2026 as well as one-time severance costs recognized in the second quarter of 2025.
filing / Aug 11, 2026 / receipt
• our headcount growth and associated costs as we expand our research and development capabilities and establish and expand our commercial infrastructure and operations;
filing / Aug 11, 2026 / receipt
• our headcount growth and associated costs as we expand our research and development capabilities and establish and expand our commercial infrastructure and operations;
filing / May 7, 2026 / receipt
executives
| Eric Hyllengren | Chief Financial Officer | receipt | |
| Kiran Nistala | Executive Vice President | - | receipt |
| Robert Lisicki | President and Chief Operating Officer | - | receipt |
| Sandeep Kulkarni | Chief Executive Officer | - | receipt |
familynone on file
upcoming
| 2026-11-12 | earnings call | scheduled | ir |
changes
| 2026-01-26 | Chief Executive Officer, appointed | sec_8k |
| 2025-07-01 | Chief Financial Officer, appointed | sec_8k |
| 2024-01-08 | President and Chief Operating Officer, appointed | sec_8k |
| 2023-12-06 | Executive Vice President, appointed | sec_8k |
mcp_package_hint
slug zura-bio-limited
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$